← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 16, 2017Last known activity
Jun 13, 2023
Acquired by Eli Lilly on Nov 10, 2025
Timeline
2010s
- Jun 1, 2015
MeiraGTx— Founded
2020s
- Nov 10, 2025
Eli Lilly— Acquired By
Drugs by trial phase (5 distinct, 10 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05926765Lead sponsorPhase 2Jun 13, 2023
- NCT05894343Lead sponsorPhase 1/Phase 2May 19, 2023
- NCT05603312Lead sponsorPhase 1/Phase 2Oct 5, 2022
- NCT04794101Lead sponsorPhase 3Mar 16, 2021
- NCT04671433Lead sponsorPhase 3Mar 16, 2021
- NCT04043104Lead sponsorPhase 1/Phase 2Jun 30, 2019
- NCT03758404Lead sponsorPhase 1/Phase 2Mar 31, 2019
- NCT03252847Lead sponsorPhase 1/Phase 2Jul 14, 2017
- NCT03278873Lead sponsorPhase 1/Phase 2Jun 27, 2017
- NCT03001310Lead sponsorPhase 1/Phase 2Jan 16, 2017
Details
- Founded
- New York, NY, US Jun 1, 2015
- Last known activity
- Jun 13, 2023